Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Oct;40(4):299–305. doi: 10.1111/j.1365-2125.1995.tb04550.x

Influence of basal nitric oxide secretion on cardiac function in man.

P B Clarkson 1, P O Lim 1, T M MacDonald 1
PMCID: PMC1365147  PMID: 8554930

Abstract

1. Nitric oxide is recognised as an important biological mediator, which is thought to be involved in cardiovascular homeostasis. The purpose of this study was to investigate the effects of basal nitric oxide synthesis on cardiac function in man, by blocking nitric oxide synthesis with NG-monomethyl-L-arginine (L-NMMA). 2. Eight normal volunteers were studied on two separate occasions. Measurements of heart rate, blood pressure and echocardiographic indices of left ventricular systolic and diastolic function were made at baseline on each day and every 20 min during incremental infusion of L-NMMA (0.1, 0.2, 0.5, 1.0 and 2.0 mg kg-1 h-1) or placebo. 3. A trend towards reduction in heart rate was observed with L-NMMA infusion although this did not reach statistical significance, whereas significant increases in both systolic blood pressure (at 2.0 mg kg-1 h-1) and systemic vascular resistance index (at 0.5 mg kg-1 h-1) were seen. 4. L-NMMA infusion caused significant reductions in stroke distance and cardiac index, although there was no change in the ratio of end systolic wall stress/end systolic volume index (an afterload independent index of left ventricular systolic performance). 5. The isovolumic relaxation time significantly increased with L-NMMA infusion, together with a significant reduction in the 'E' wave flow velocity integral. Reductions in both peak E/A ratio and E/A flow velocity integral ratio were also seen, although these failed to reach statistical significance. 6. In conclusion, the basal generation of nitric oxide in man appears to maintain a vasodilated state, and modifies left ventricular diastolic filling parameters.

Full text

PDF
299

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brady A. J., Warren J. B., Poole-Wilson P. A., Williams T. J., Harding S. E. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993 Jul;265(1 Pt 2):H176–H182. doi: 10.1152/ajpheart.1993.265.1.H176. [DOI] [PubMed] [Google Scholar]
  2. Brutsaert D. L., Meulemans A. L., Sipido K. R., Sys S. U. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res. 1988 Feb;62(2):358–366. doi: 10.1161/01.res.62.2.358. [DOI] [PubMed] [Google Scholar]
  3. Calver A., Collier J., Moncada S., Vallance P. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992 Sep;10(9):1025–1031. [PubMed] [Google Scholar]
  4. Choong C. Y., Herrmann H. C., Weyman A. E., Fifer M. A. Preload dependence of Doppler-derived indexes of left ventricular diastolic function in humans. J Am Coll Cardiol. 1987 Oct;10(4):800–808. doi: 10.1016/s0735-1097(87)80273-5. [DOI] [PubMed] [Google Scholar]
  5. Clarkson P. B., Wheeldon N. M., MacLeod C., Tennent M., MacDonald T. M. Effects of angiotensin II and aldosterone on diastolic function in vivo in normal man. Clin Sci (Lond) 1994 Oct;87(4):397–401. doi: 10.1042/cs0870397. [DOI] [PubMed] [Google Scholar]
  6. Clarkson P., Wheeldon N. M., Macdonald T. M. Left ventricular diastolic dysfunction. Q J Med. 1994 Mar;87(3):143–148. [PubMed] [Google Scholar]
  7. D'Orléans-Juste P., Lidbury P. S., Telemaque S., Warner T. D., Vane J. R. Human big endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1. J Cardiovasc Pharmacol. 1991;17 (Suppl 7):S251–S255. doi: 10.1097/00005344-199100177-00072. [DOI] [PubMed] [Google Scholar]
  8. Devereux R. B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977 Apr;55(4):613–618. doi: 10.1161/01.cir.55.4.613. [DOI] [PubMed] [Google Scholar]
  9. Habib F., Dutka D., Crossman D., Oakley C. M., Cleland J. G. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet. 1994 Aug 6;344(8919):371–373. doi: 10.1016/s0140-6736(94)91402-8. [DOI] [PubMed] [Google Scholar]
  10. Haynes W. G., Noon J. P., Walker B. R., Webb D. J. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993 Dec;11(12):1375–1380. doi: 10.1097/00004872-199312000-00009. [DOI] [PubMed] [Google Scholar]
  11. Haynes W. G., Webb D. J. The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci (Lond) 1993 May;84(5):485–500. doi: 10.1042/cs0840485. [DOI] [PubMed] [Google Scholar]
  12. Lenfant C. NHLBI funding policies. Enhancing stability, predictability, and cost control. Circulation. 1994 Jul;90(1):1–1. doi: 10.1161/01.cir.90.1.1. [DOI] [PubMed] [Google Scholar]
  13. Linder L., Kiowski W., Bühler F. R., Lüscher T. F. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation. 1990 Jun;81(6):1762–1767. doi: 10.1161/01.cir.81.6.1762. [DOI] [PubMed] [Google Scholar]
  14. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002–2012. doi: 10.1056/NEJM199312303292706. [DOI] [PubMed] [Google Scholar]
  15. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  16. Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664–666. doi: 10.1038/333664a0. [DOI] [PubMed] [Google Scholar]
  17. Palmer R. M., Rees D. D., Ashton D. S., Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988 Jun 30;153(3):1251–1256. doi: 10.1016/s0006-291x(88)81362-7. [DOI] [PubMed] [Google Scholar]
  18. Panza J. A., Quyyumi A. A., Brush J. E., Jr, Epstein S. E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990 Jul 5;323(1):22–27. doi: 10.1056/NEJM199007053230105. [DOI] [PubMed] [Google Scholar]
  19. Paulus W. J., Vantrimpont P. J., Shah A. M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation. 1994 May;89(5):2070–2078. doi: 10.1161/01.cir.89.5.2070. [DOI] [PubMed] [Google Scholar]
  20. Pearson A. C., Gudipati C. V., Labovitz A. J. Systolic and diastolic flow abnormalities in elderly patients with hypertensive hypertrophic cardiomyopathy. J Am Coll Cardiol. 1988 Oct;12(4):989–995. doi: 10.1016/0735-1097(88)90466-4. [DOI] [PubMed] [Google Scholar]
  21. Pearson A. C., Labovitz A. J., Mrosek D., Williams G. A., Kennedy H. L. Assessment of diastolic function in normal and hypertrophied hearts: comparison of Doppler echocardiography and M-mode echocardiography. Am Heart J. 1987 Jun;113(6):1417–1425. doi: 10.1016/0002-8703(87)90657-0. [DOI] [PubMed] [Google Scholar]
  22. Pombo J. F., Troy B. L., Russell R. O., Jr Left ventricular volumes and ejection fraction by echocardiography. Circulation. 1971 Apr;43(4):480–490. doi: 10.1161/01.cir.43.4.480. [DOI] [PubMed] [Google Scholar]
  23. Radomski M. W., Palmer R. M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987 Nov 7;2(8567):1057–1058. doi: 10.1016/s0140-6736(87)91481-4. [DOI] [PubMed] [Google Scholar]
  24. Ramaciotti C., Sharkey A., McClellan G., Winegrad S. Endothelial cells regulate cardiac contractility. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4033–4036. doi: 10.1073/pnas.89.9.4033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Reichek N., Wilson J., St John Sutton M., Plappert T. A., Goldberg S., Hirshfeld J. W. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation. 1982 Jan;65(1):99–108. doi: 10.1161/01.cir.65.1.99. [DOI] [PubMed] [Google Scholar]
  26. Richard V., Hogie M., Clozel M., Löffler B. M., Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation. 1995 Feb 1;91(3):771–775. doi: 10.1161/01.cir.91.3.771. [DOI] [PubMed] [Google Scholar]
  27. Shapiro L. M., Gibson D. G. Patterns of diastolic dysfunction in left ventricular hypertrophy. Br Heart J. 1988 Apr;59(4):438–445. doi: 10.1136/hrt.59.4.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Spirito P., Maron B. J., Bonow R. O. Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol. 1986 Mar;7(3):518–526. doi: 10.1016/s0735-1097(86)80461-2. [DOI] [PubMed] [Google Scholar]
  29. Thomas J. D., Flachskampf F. A., Chen C., Guererro J. L., Picard M. H., Levine R. A., Weyman A. E. Isovolumic relaxation time varies predictably with its time constant and aortic and left atrial pressures: implications for the noninvasive evaluation of ventricular relaxation. Am Heart J. 1992 Nov;124(5):1305–1313. doi: 10.1016/0002-8703(92)90416-s. [DOI] [PubMed] [Google Scholar]
  30. Triulzi M. O., Castini D., Ornaghi M., Vitolo E. Effects of preload reduction on mitral flow velocity pattern in normal subjects. Am J Cardiol. 1990 Oct 15;66(12):995–1001. doi: 10.1016/0002-9149(90)90939-x. [DOI] [PubMed] [Google Scholar]
  31. Vallance P., Leone A., Calver A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992 Mar 7;339(8793):572–575. doi: 10.1016/0140-6736(92)90865-z. [DOI] [PubMed] [Google Scholar]
  32. Wallerson D. C., Ganau A., Roman M. J., Devereux R. B. Measurement of cardiac output by M-mode and two-dimensional echocardiography: application to patients with hypertension. Eur Heart J. 1990 Dec;11 (Suppl 1):67–78. doi: 10.1093/eurheartj/11.suppl_i.67. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES